As of October 17, 2023, the company has received $56,000,000 in its first tranche. The transaction was led by returning investor Eclipse Ventures, LLC and new investor GE HealthCare Technologies Inc. The transaction also included participation from returning investor Mayo Clinic, new investors Echo Global Logistics, Inc., Fox Chase Cancer Center Medical Group, Inc., Granger Management LLC, University of Missouri, Mercy Health. This funding round was over-subscribed.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
88.94 USD | +3.13% | +5.49% | +15.03% |
04:09pm | GE HealthCare Technologies Receives FDA Marketing Clearance for Portrait VSM Monitor | MT |
Apr. 22 | Elekta, GE HealthCare Team Up for New Cancer Treatment Planning Services | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.03% | 39.35B | |
+8.69% | 219B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 108B | |
+0.27% | 63.06B | |
+12.72% | 52.02B | |
+3.96% | 48.2B | |
+0.40% | 40.37B | |
+26.26% | 32.03B |
- Stock Market
- Equities
- GEHC Stock
- News GE HealthCare Technologies Inc.
- Nucleus RadioPharma, Inc. announces tranche update